Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
lead research manager of projects. Extended stay and travel throughout Africa is required. • Organizing and collecting data – helping coordinate research assistants and staff to support these
-
of the Canadian Pharmacogenomics Network for Drug Safety (CPNDS). We are seeking scientists to lead research projects with a specific focus on the genetic determinants of severe adverse drug and vaccine reactions
-
laboratory of Dr. Bruce Carleton and the multi-centre research team of the Canadian Pharmacogenomics Network for Drug Safety (CPNDS). We are seeking scientists to lead research projects with a specific focus
-
and the multi-centre research team of the Canadian Pharmacogenomics Network for Drug Safety (CPNDS). We are seeking scientists to lead research projects with a specific focus on the genetic determinants
-
Institut national de la recherche scientifique (INRS) | Varennes, Quebec | Canada | about 19 hours ago
on the coincident detection of two electrons emitted by two photons of the same ultraviolet probe pulse and promises direct access to the two-particle correlation function with momentum resolution. The design
-
, fiber, and fuel demands as the world’s population races toward a projected 9 billion by 2050 concomitant with diminishing land and water resources and increasingly variable climatic conditions. In
-
projects with a specific focus on the genetic determinants of severe adverse drug and vaccine reactions. Potential projects focus on severe ADRs to a range of different medications. Current priority ADRs
-
on medical cannabis from basic science, clinical, health services and policy perspectives Improving self-management tools and technology enablers to help manage and communicate about pain Osteoarthritis (OA
-
and we work to embed them in all that we do. Toronto Metropolitan University welcomes those who have demonstrated a commitment to upholding the values of equity, diversity, and inclusion and will assist
-
therapies. Assist in designing the iCT design, with consideration of multi-arm multi-stage, adaptive dose-ranging, group-sequential (early termination), or population enrichment Engage in knowledge